 |
The Journal of Neuroscience, November 19, 2003, 23(33):10681-10690
Previous Article | Next Article 
Cellular/Molecular
Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia
Sang Won Suh,1,3
Koji Aoyama,1,3
Yongmei Chen,1,3
Philippe Garnier,1,3
Yasuhiko Matsumori,2,3
Elizabeth Gum,1,3
Jialing Liu,2,3 and
Raymond A. Swanson1,3
Departments of 1Neurology and 2Neurosurgery, University of California, San Francisco, California 94143, and 3Veterans Affairs Medical Center, San Francisco, California 94121
Severe hypoglycemia causes neuronal death and cognitive impairment. Evidence suggests that hypoglycemic neuronal death involves excitotoxicity and DNA damage. Poly(ADP-ribose) polymerase-1 (PARP-1) normally functions in DNA repair, but promotes cell death when extensively activated by DNA damage. Cortical neuron cultures were subjected to glucose deprivation to assess the role of PARP-1 in hypoglycemic neuronal death. PARP-1-/- neurons and wild-type, PARP-1+/+ neurons treated with the PARP inhibitor 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone both showed increased resistance to glucose deprivation. A rat model of insulin-induced hypoglycemia was used to assess the therapeutic potential of PARP inhibitors after hypoglycemia. Rats subjected to severe hypoglycemia (30 min EEG isoelectricity) accumulated both nitrotyrosine and the PARP-1 product, poly(ADP-ribose), in vulnerable neurons. Treatment with PARP inhibitors immediately after hypoglycemia blocked production of poly(ADP-ribose) and reduced neuronal death by >80% in most brain regions examined. Increased neuronal survival was also achieved when PARP inhibitors were administered up to 2 hr after blood glucose correction. Behavioral and histological assessments performed 6 weeks after hypoglycemia confirmed a sustained salutary effect of PARP inhibition. These results suggest that PARP-1 activation is a major factor mediating hypoglycemic neuronal death and that PARP-1 inhibitors can rescue neurons that would otherwise die after severe hypoglycemia.
Key words: diabetes; glucose; glutamate; neuron; nitrotyrosine; water maze; 7-nitroindazole; 3-aminobenzamide
Received April 29, 2001;
revised September 10, 2003;
accepted September 26, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Bree, E. C. Puente, D. Daphna-Iken, and S. J. Fisher
Diabetes increases brain damage caused by severe hypoglycemia
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E194 - E201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schmidt, M. Richter, D. Montag, T. Sartorius, V. Gawlik, A. M. Hennige, S. Scherneck, H. Himmelbauer, S. Z. Lutz, R. Augustin, et al.
Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice
Am J Physiol Endocrinol Metab,
November 1, 2008;
295(5):
E1084 - E1094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Kauppinen, Y. Higashi, S. W. Suh, C. Escartin, K. Nagasawa, and R. A. Swanson
Zinc Triggers Microglial Activation
J. Neurosci.,
May 28, 2008;
28(22):
5827 - 5835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Suh, J. P. Bergher, C. M. Anderson, J. L. Treadway, K. Fosgerau, and R. A. Swanson
Astrocyte Glycogen Sustains Neuronal Activity during Hypoglycemia: Studies with the Glycogen Phosphorylase Inhibitor CP-316,819 ([R-R*,S*]-5-Chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide)
J. Pharmacol. Exp. Ther.,
April 1, 2007;
321(1):
45 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Hamby, S. W. Suh, T. M. Kauppinen, and R. A. Swanson
Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion
Stroke,
February 1, 2007;
38(2):
632 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Kauppinen, W. Y. Chan, S. W. Suh, A. K. Wiggins, E. J. Huang, and R. A. Swanson
Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2
PNAS,
May 2, 2006;
103(18):
7136 - 7141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Suh, K. Aoyama, Y. Matsumori, J. Liu, and R. A. Swanson
Pyruvate Administered After Severe Hypoglycemia Reduces Neuronal Death and Cognitive Impairment
Diabetes,
May 1, 2005;
54(5):
1452 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Kauppinen and R. A. Swanson
Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death
J. Immunol.,
February 15, 2005;
174(4):
2288 - 2296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Suh, Y. Fan, S. M. Hong, Z. Liu, Y. Matsumori, P. R. Weinstein, R. A. Swanson, and J. Liu
Hypoglycemia Induces Transient Neurogenesis and Subsequent Progenitor Cell Loss in the Rat Hippocampus
Diabetes,
February 1, 2005;
54(2):
500 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iwashita, S. Yamazaki, K. Mihara, K. Hattori, H. Yamamoto, J. Ishida, N. Matsuoka, and S. Mutoh
Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson's Disease
J. Pharmacol. Exp. Ther.,
June 1, 2004;
309(3):
1067 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|